Sanofi-Synthelabo Korea Reports Financial Performance Results
Published: 2005-04-12 06:57:00
Updated: 2005-04-12 06:57:00
Sanofi-Synthelabo Korea (currently Sanofi-Aventis after the merge between Sanofi-Synthelabo and Aventis) reported the financial performance results from last year, in which the company recorded the sales of 162.0 billion won, up 40% from the prior period.
The company's operating profit was 27....
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
